Zealand Pharma A/S
ZLDPF
$75.88
-$7.17-8.63%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -61.31% | 2,827.35% | -42.09% | -8.82% | -462.54% |
| Total Depreciation and Amortization | 24.03% | -3.18% | -12.76% | -0.88% | 48.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | 1,264.45% | -- |
| Total Other Non-Cash Items | 762.42% | 2,286.30% | 162.28% | -177.01% | -29.50% |
| Change in Net Operating Assets | -978.81% | -1,192.39% | -3,707.33% | -49.60% | 90.72% |
| Cash from Operations | -59.73% | 3,982.45% | -116.90% | -400.20% | -164.41% |
| Capital Expenditure | -1,438.54% | -32.93% | -77.09% | 82.67% | 69.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 85.09% | -6,326.65% | 137.87% | 1,020.96% | -3,907.07% |
| Cash from Investing | 85.03% | -5,354.78% | 138.98% | 2,128.12% | -3,927.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -29.57% | -15.92% | -12.45% | 46.85% | -55.74% |
| Issuance of Common Stock | -62.82% | -99.62% | -99.76% | -99.45% | -23.99% |
| Repurchase of Common Stock | 72.39% | -310.23% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 82.91% | -- |
| Cash from Financing | 69.43% | -104.84% | -100.04% | -181.44% | -6,913.23% |
| Foreign Exchange rate Adjustments | 5,865.50% | -18,757.00% | -178.04% | 151.65% | -137.51% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 79.66% | 5.18% | -78.24% | -146.87% | -11,912.59% |